Stacey Gabriel, Ph.D.
Executive Vice President, Head of Platforms and Scientific Execution, Institute Scientist
Stacey Gabriel is the executive vice president, head of platforms and scientific execution at ӳý of MIT and Harvard, and has led platform development, execution, and operation since the institute’s founding in 2003. She is an Institute Scientist and serves on the institute’s Executive Leadership Team.
Gabriel is widely recognized as a leader in genomics technology and application to foundational research programs. As a principal investigator of the ӳý All of Us Genomics Center and member of the All of Us Program Steering Committee, Gabriel is an expert in building biobanks, including scalable, cost-effective genomic data generation and analysis. She is also pioneering methods for multi-omic data analysis and integration.
Her early work was foundational to the International HapMap Project, which made it possible to identify genetic variations that influence the risk of human disease. She has led the ӳý’s contributions to that project and numerous flagship resource-building programs in human genetics including the 1000 Genomes Project, The Cancer Genome Atlas (TCGA), and the TOPMed program.
In response to the COVID-19 pandemic, Gabriel led the development and execution of ӳý's viral diagnostic and sequencing effort. The lab rapidly became the largest single testing lab in New England and delivered almost 38 million diagnostic test results in a three-year period. For the work she was recognized by the Boston Globe as a “Bostonian of the Year” in 2020.
She has been recognized by Clarivate Analytics as one of the most highly cited scientists in molecular biology and genetics in the world six years in a row and recently named on the “Best Female Scientists in the World,” ranking 22nd.
Gabriel received her B.S. in molecular biology from Carnegie Mellon University and Ph.D. in human genetics from Case Western Reserve University.
Areas of expertise: genomics; genomics technologies; multi-omics technologies and data analysis; biobanks; scalable science and technology; cost-effective research and clinical diagnostics
Casey Atkins Photography
February 2026
